Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Neutralization Tests | 8 | 2021 | 6698 | 1.25 | Why? |
| Viral Plaque Assay | 3 | 2020 | 381 | 0.82 | Why? |
| Organisms, Genetically Modified | 1 | 2020 | 59 | 0.82 | Why? |
| Zika Virus | 9 | 2020 | 1924 | 0.79 | Why? |
| Reverse Genetics | 2 | 2021 | 439 | 0.79 | Why? |
| DNA, Complementary | 3 | 2020 | 568 | 0.77 | Why? |
| Genetic Engineering | 1 | 2021 | 325 | 0.74 | Why? |
| Mutation | 10 | 2021 | 12376 | 0.62 | Why? |
| Zika Virus Infection | 7 | 2018 | 1920 | 0.56 | Why? |
| High-Throughput Screening Assays | 2 | 2020 | 1783 | 0.47 | Why? |
| Vero Cells | 17 | 2021 | 14117 | 0.36 | Why? |
| Dengue Vaccines | 2 | 2018 | 123 | 0.32 | Why? |
| Spike Glycoprotein, Coronavirus | 11 | 2021 | 37182 | 0.32 | Why? |
| Antibodies, Neutralizing | 16 | 2021 | 25288 | 0.30 | Why? |
| Virus Replication | 11 | 2021 | 14331 | 0.30 | Why? |
| Dengue Virus | 4 | 2020 | 910 | 0.27 | Why? |
| Methyltransferases | 2 | 2020 | 720 | 0.25 | Why? |
| Animals | 28 | 2021 | 78931 | 0.25 | Why? |
| Clone Cells | 2 | 2021 | 312 | 0.25 | Why? |
| Antibodies, Viral | 11 | 2021 | 51949 | 0.22 | Why? |
| Antiviral Agents | 6 | 2021 | 41703 | 0.22 | Why? |
| A549 Cells | 3 | 2021 | 2066 | 0.21 | Why? |
| DNA Topoisomerases, Type I | 1 | 2020 | 86 | 0.20 | Why? |
| Cricetinae | 7 | 2021 | 3344 | 0.20 | Why? |
| Fragile X Mental Retardation Protein | 1 | 2018 | 9 | 0.20 | Why? |
| Luciferases | 1 | 2020 | 378 | 0.19 | Why? |
| Defective Viruses | 1 | 2018 | 98 | 0.19 | Why? |
| Antibodies, Monoclonal | 4 | 2021 | 8041 | 0.18 | Why? |
| Genes, Reporter | 1 | 2020 | 472 | 0.18 | Why? |
| Genetic Fitness | 1 | 2020 | 339 | 0.18 | Why? |
| Virus Assembly | 2 | 2018 | 438 | 0.18 | Why? |
| Germinal Center | 1 | 2021 | 332 | 0.18 | Why? |
| Plasma Cells | 1 | 2021 | 464 | 0.18 | Why? |
| Lipopeptides | 1 | 2020 | 229 | 0.17 | Why? |
| Mice | 14 | 2021 | 21357 | 0.17 | Why? |
| Capsid Proteins | 1 | 2020 | 365 | 0.17 | Why? |
| RNA Helicases | 1 | 2020 | 413 | 0.17 | Why? |
| Genome, Viral | 6 | 2021 | 13157 | 0.16 | Why? |
| Cricetulus | 4 | 2021 | 936 | 0.15 | Why? |
| Microspheres | 1 | 2017 | 261 | 0.15 | Why? |
| Containment of Biohazards | 1 | 2021 | 762 | 0.14 | Why? |
| Viral Nonstructural Proteins | 4 | 2020 | 4810 | 0.14 | Why? |
| Vaccines, Synthetic | 3 | 2021 | 3231 | 0.13 | Why? |
| Furin | 1 | 2021 | 1054 | 0.13 | Why? |
| Immunoglobulin M | 2 | 2021 | 9091 | 0.13 | Why? |
| Immunoassay | 2 | 2020 | 4485 | 0.12 | Why? |
| RNA Viruses | 1 | 2020 | 824 | 0.12 | Why? |
| Protein Binding | 4 | 2021 | 11430 | 0.12 | Why? |
| Virus Internalization | 2 | 2020 | 7921 | 0.11 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.11 | Why? |
| Pain | 1 | 2019 | 1084 | 0.11 | Why? |
| Vaccines, DNA | 1 | 2017 | 871 | 0.10 | Why? |
| DNA, Viral | 1 | 2021 | 2521 | 0.10 | Why? |
| Immune Evasion | 1 | 2020 | 2081 | 0.10 | Why? |
| Immunity, Herd | 1 | 2018 | 1011 | 0.10 | Why? |
| Mice, Transgenic | 3 | 2021 | 2739 | 0.10 | Why? |
| HEK293 Cells | 5 | 2021 | 8394 | 0.10 | Why? |
| Disease Models, Animal | 4 | 2021 | 10998 | 0.09 | Why? |
| Immunogenicity, Vaccine | 2 | 2021 | 4624 | 0.09 | Why? |
| Dengue | 2 | 2018 | 1565 | 0.09 | Why? |
| Drug Design | 1 | 2021 | 2627 | 0.09 | Why? |
| Viral Envelope Proteins | 2 | 2017 | 3539 | 0.09 | Why? |
| Viral Vaccines | 2 | 2020 | 7560 | 0.09 | Why? |
| Humans | 33 | 2021 | 930598 | 0.08 | Why? |
| Interferons | 1 | 2020 | 2885 | 0.08 | Why? |
| Point-of-Care Testing | 1 | 2020 | 2782 | 0.08 | Why? |
| Interferon Type I | 1 | 2020 | 2789 | 0.08 | Why? |
| Administration, Intranasal | 2 | 2021 | 1132 | 0.08 | Why? |
| Reagent Kits, Diagnostic | 1 | 2017 | 2149 | 0.08 | Why? |
| Mesocricetus | 2 | 2021 | 1847 | 0.07 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.07 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.07 | Why? |
| Drug Discovery | 1 | 2017 | 3092 | 0.06 | Why? |
| RNA, Viral | 6 | 2021 | 32276 | 0.06 | Why? |
| Cell Line | 4 | 2021 | 12040 | 0.06 | Why? |
| Nurses | 1 | 2019 | 2285 | 0.06 | Why? |
| Testis | 2 | 2018 | 566 | 0.06 | Why? |
| Immunoglobulin G | 3 | 2021 | 21571 | 0.06 | Why? |
| Serine C-Palmitoyltransferase | 1 | 2021 | 20 | 0.06 | Why? |
| Virion | 2 | 2021 | 1444 | 0.06 | Why? |
| Virulence | 2 | 2021 | 2172 | 0.06 | Why? |
| Genetic Complementation Test | 1 | 2021 | 59 | 0.06 | Why? |
| Untranslated Regions | 1 | 2021 | 25 | 0.06 | Why? |
| Viral Proteins | 1 | 2020 | 7370 | 0.06 | Why? |
| Electroporation | 1 | 2021 | 52 | 0.06 | Why? |
| Immunoglobulin Fragments | 1 | 2021 | 78 | 0.06 | Why? |
| alpha Karyopherins | 1 | 2020 | 44 | 0.05 | Why? |
| Mice, Inbred BALB C | 2 | 2021 | 5814 | 0.05 | Why? |
| Apoptosis Regulatory Proteins | 1 | 2021 | 202 | 0.05 | Why? |
| Tissue Culture Techniques | 1 | 2020 | 158 | 0.05 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2017 | 5164 | 0.05 | Why? |
| STAT Transcription Factors | 1 | 2020 | 173 | 0.05 | Why? |
| Mutant Proteins | 1 | 2021 | 328 | 0.05 | Why? |
| Dose-Response Relationship, Immunologic | 1 | 2021 | 593 | 0.05 | Why? |
| Gene Knockout Techniques | 1 | 2020 | 347 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| Nerve Tissue Proteins | 1 | 2021 | 319 | 0.05 | Why? |
| Amino Acid Sequence | 2 | 2021 | 6049 | 0.05 | Why? |
| Yellow fever virus | 1 | 2020 | 205 | 0.05 | Why? |
| Mice, Inbred C57BL | 2 | 2021 | 5542 | 0.05 | Why? |
| CHO Cells | 1 | 2021 | 831 | 0.05 | Why? |
| Pregnancy | 2 | 2017 | 23879 | 0.04 | Why? |
| Protein Engineering | 1 | 2021 | 536 | 0.04 | Why? |
| Interferon Regulatory Factor-3 | 1 | 2020 | 379 | 0.04 | Why? |
| Inhibitory Concentration 50 | 1 | 2021 | 907 | 0.04 | Why? |
| Gene Knockdown Techniques | 1 | 2018 | 347 | 0.04 | Why? |
| Protein Stability | 1 | 2020 | 756 | 0.04 | Why? |
| 3' Untranslated Regions | 1 | 2018 | 318 | 0.04 | Why? |
| Epidemics | 1 | 2018 | 6407 | 0.04 | Why? |
| Drug Evaluation, Preclinical | 2 | 2021 | 3347 | 0.04 | Why? |
| Proteolysis | 1 | 2021 | 751 | 0.04 | Why? |
| Occupational Injuries | 1 | 2019 | 148 | 0.04 | Why? |
| Post-Exposure Prophylaxis | 1 | 2021 | 472 | 0.04 | Why? |
| Bone Marrow Cells | 1 | 2017 | 186 | 0.04 | Why? |
| Models, Molecular | 2 | 2021 | 7616 | 0.04 | Why? |
| Membrane Fusion | 1 | 2020 | 713 | 0.04 | Why? |
| Culicidae | 1 | 2018 | 239 | 0.04 | Why? |
| Insect Vectors | 1 | 2017 | 227 | 0.04 | Why? |
| Trachea | 1 | 2020 | 894 | 0.04 | Why? |
| Healthy Volunteers | 1 | 2021 | 1444 | 0.04 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.04 | Why? |
| Female | 10 | 2021 | 380317 | 0.04 | Why? |
| Serine Endopeptidases | 2 | 2021 | 4606 | 0.04 | Why? |
| HeLa Cells | 1 | 2018 | 1303 | 0.04 | Why? |
| Protein Biosynthesis | 1 | 2018 | 653 | 0.03 | Why? |
| Aedes | 1 | 2017 | 380 | 0.03 | Why? |
| Transfection | 1 | 2017 | 864 | 0.03 | Why? |
| Open Reading Frames | 1 | 2021 | 1898 | 0.03 | Why? |
| Job Satisfaction | 1 | 2019 | 647 | 0.03 | Why? |
| Adenosine Monophosphate | 2 | 2021 | 5652 | 0.03 | Why? |
| Alanine | 2 | 2021 | 5687 | 0.03 | Why? |
| Plasmids | 1 | 2017 | 840 | 0.03 | Why? |
| Ebolavirus | 1 | 2020 | 834 | 0.03 | Why? |
| Glycosylation | 1 | 2017 | 1255 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Macaca fascicularis | 1 | 2018 | 1009 | 0.03 | Why? |
| Protein Structure, Tertiary | 1 | 2017 | 1565 | 0.03 | Why? |
| Nasal Mucosa | 1 | 2020 | 1218 | 0.03 | Why? |
| Kinetics | 1 | 2021 | 3238 | 0.03 | Why? |
| Pre-Exposure Prophylaxis | 1 | 2021 | 1138 | 0.03 | Why? |
| Male | 10 | 2021 | 367725 | 0.03 | Why? |
| Vaccines, Attenuated | 1 | 2017 | 952 | 0.03 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2018 | 7868 | 0.03 | Why? |
| Respiratory Mucosa | 1 | 2020 | 1522 | 0.03 | Why? |
| Mutation, Missense | 1 | 2017 | 863 | 0.03 | Why? |
| Pain Management | 1 | 2019 | 854 | 0.03 | Why? |
| Viral Load | 2 | 2021 | 15850 | 0.03 | Why? |
| Vaccines, Inactivated | 1 | 2017 | 1562 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2021 | 3567 | 0.02 | Why? |
| Dendritic Cells | 1 | 2017 | 1330 | 0.02 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.02 | Why? |
| Influenza A virus | 1 | 2020 | 2234 | 0.02 | Why? |
| Lung | 3 | 2021 | 31049 | 0.02 | Why? |
| Protein Domains | 1 | 2020 | 6563 | 0.02 | Why? |
| Lung Diseases | 1 | 2021 | 2361 | 0.02 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.02 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.02 | Why? |
| Sensitivity and Specificity | 2 | 2017 | 22971 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2021 | 6740 | 0.02 | Why? |
| Cross Reactions | 1 | 2017 | 4374 | 0.02 | Why? |
| Receptors, Virus | 1 | 2021 | 5659 | 0.02 | Why? |
| Models, Biological | 1 | 2020 | 4907 | 0.02 | Why? |
| Occupational Health | 1 | 2019 | 3965 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2017 | 11041 | 0.01 | Why? |
| Cytokines | 1 | 2017 | 15010 | 0.01 | Why? |
| Adult | 2 | 2021 | 244371 | 0.01 | Why? |
| China | 1 | 2019 | 50654 | 0.01 | Why? |
| Middle Aged | 2 | 2021 | 270681 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2019 | 43792 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2018 | 48226 | 0.01 | Why? |
| Young Adult | 1 | 2019 | 93724 | 0.01 | Why? |
| Aged | 1 | 2021 | 215776 | 0.00 | Why? |
Xie's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(176)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(265)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_